Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2021 Apr 15.
Published in final edited form as: J Acquir Immune Defic Syndr. 2020 Apr 15;83(5):450–456. doi: 10.1097/QAI.0000000000002297

PrEP4Love: The Role of Messaging and Prevention Advocacy in PrEP Attitudes, Perceptions, and Uptake Among YMSM and Transgender Women

Gregory Phillips II 1,2,5, Anand B Raman 1,2, Dylan Felt 1,2, David J McCuskey 1,2, Christina S Hayford 3, Jim Pickett 4, Peter T Lindeman 1,2, Brian Mustanski 1
PMCID: PMC7083076  NIHMSID: NIHMS1549613  PMID: 31939870

Abstract

Background:

Despite high efficacy, use of pre-exposure prophylaxis (PrEP) remains low among young men who have sex with men (MSM) and transgender women (TW), primarily due to barriers such as stigma and resource awareness. We evaluated a social marketing campaign known as PrEP4Love that works to eliminate PrEP stigma and awareness gaps via targeted advertising.

Setting:

Chicago, Illinois.

Methods:

Participants were enrolled within a cohort study of young MSM and TW (RADAR). Data were collected between June 2017 and April 2018 from HIV-negative individuals attending a follow-up visit. Surveys assessed demographics, PrEP attitudes and perceptions, and PrEP4Love campaign awareness. Associations between PrEP4Love awareness and PrEP perceptions, uptake, and behaviors were assessed using multiple logistic regression controlling for age, race/ethnicity, gender, sexual identity, and ever having used PrEP.

Results:

Of 700 participants, the majority (75.9%) indicated seeing PrEP4Love ads in Chicago. Those who had seen ads were more likely to be out to their providers (OR =1.95; 95% CI: 1.17, 3.23) than those who had not, and those who had conversations were significantly more likely to have initiated the conversation themselves. Individuals who had seen ads were more likely to have taken PrEP in the last six months (OR = 1.87; 95% CI: 1.15, 3.16), and more likely to believe their friends and the general public approved of and used PrEP.

Conclusion:

Social marketing campaigns are promising interventions that have the potential to alleviate barriers to HIV prevention, particularly among MSM and TW. Future research should evaluate the impact of these initiatives at multiple time points.

Keywords: PrEP, Prevention, Education, Mobilization, Uptake, Attitudes

INTRODUCTION

In the United States (US), over 1.1 million individuals are currently living with HIV,1 with certain demographics disproportionately impacted. Gay, bisexual, and other men who have sex with men (MSM) accounted for 70% of new HIV diagnoses overall in 2017, including 83% of new diagnoses among men.2,3 This disparity is especially pronounced among Black MSM (BMSM),2,4,5 Latinx MSM (LMSM),3,6 and young MSM (YMSM).2,7 Likewise, transgender women (TW) are disproportionately impacted; a staggering 56% of Black TW are estimated to be living with HIV.8

Pre-exposure prophylaxis (PrEP) is an effective prevention strategy for HIV-negative individuals. Taken as prescribed, PrEP can reduce risk of contracting HIV by 92–99%.911 Since market approval of Truvada for PrEP in 2012, there has been an increase in PrEP awareness among MSM;12 however, this has not resulted in a sufficient increase (defined by the Getting to Zero Illinois [GTZ-IL] initiative as a 20% increase in use of PrEP)13 in uptake, particularly among vulnerable populations.1419

Commonly cited barriers to PrEP use include cost, adherence regimen, and access to a prescription or insurance.20 Social dynamics are also key: BMSM and LMSM in particular cite PrEP stigma as a barrier to uptake.21 For example, the belief that men who take PrEP are more promiscuous or likely to engage in risky sexual behavior may discourage PrEP use for some MSM.22 Furthermore, medical mistrust and conspiracy beliefs surrounding PrEP and the overall health system are more common among Black MSM and TW, and are unsurprisingly related to disinterest in PrEP.23 One study of Black gay and bisexual men (GBM) indicated that medical mistrust, culturally insensitive health care for gay men, and concerns regarding side effects were most related to low uptake.24 TW also experience unique barriers to PrEP use, such as lack of trans-inclusive marketing, prioritisation of hormone use, and medical mistrust due to transphobia.25 Considering these concerns, there is an evident need for culturally responsive interventions to encourage PrEP uptake among populations most impacted by HIV.

Targeted messaging – the diffusion of information through content-specific communication for certain populations – represents a potentially impactful means of addressing barriers to PrEP uptake; mass media campaigns have previously demonstrated efficacy in health promotion.2629 Although existing campaigns have primarily focused on decreasing smoking or alcohol consumption, a recent review concluded that social media campaigns are a promising messaging tool for HIV prevention.30 Moreover, one Chicago-based study of young MSM and TW found that increased PrEP knowledge was associated with lower stigma, indicating that knowledge-based messaging may help to remove barriers to PrEP uptake.31 However, there remains an ongoing debate regarding the efficacy of direct-to-consumer advertising of prescription medicines such as PrEP,3235 indicating a need to evaluate the potential impact these campaigns may have on beliefs and behaviors of PrEP-eligible individuals.

PrEP4Love, a PrEP messaging and prevention-advocacy campaign led by the AIDS Foundation of Chicago and the Illinois PrEP Working Group (IPWG), represents an opportunity to test this impact. Launched in February 2016, PrEP4Love promotes PrEP in a variety of paid and unpaid Chicago advertising locations (e.g., event spaces, transit, health service providers) and via social media (e.g., Instagram and Facebook accounts) using sex-positive messaging designed to prioritize intimacy, pleasure, and peace of mind in sexual encounters.

PrEP4Love re-appropriated the epidemiological language of disease transmission and applied it to sex-positive messages (e.g., “spread tingle” or “transmit love”). PrEP4Love also uses depictions of real local couples with a variety of racial identities, gender identities, and sexual orientations to promote engagement with diverse audiences. Promotional materials linked to online resources supporting PrEP initiation and uptake, such as hotlines and service provider webs that noted geographic location and information of various Illinois PrEP providers, including services for Spanish-speaking patients. Live events organized and facilitated by community members and partners acted as a means of fostering community conversations and mobilizing people around PrEP uptake in various settings.

To assess the successes and limitations of the PrEP4Love campaign, this study leveraged an existing Chicago-based cohort of diverse YMSM and TW, exploring associations between an independent variable of exposure to PrEP4Love messaging and dependendent variables of perceptions and beliefs surrounding PrEP use and stigma, PrEP uptake-related behaviors, and current/past PrEP use.

METHODS

Data were collected within RADAR, a Chicago-based longitudinal cohort study focused on understanding individual, dyadic, network, social, and biologic factors associated with HIV infection among youth assigned male at birth. Study participants complete an initial in-person, interviewer-administered assessment that includes a network survey, an individual-level psychosocial survey, and collection of biological samples for HIV/STI testing. Follow-up visits occur every six months for the duration of the study. Participants are compensated for all study visits. RADAR was reviewed by the Northwestern University Institutional Review Board and given full ethical approval. Data for this manuscript came from participants who attended a visit between June 6, 2017 and April 27, 2018, were HIV-negative, and were administered the PrEP4Love items, resulting in an analytic sample of 700. For participants who completed the survey at multiple visits, only their first survey was included.

PrEP4Love Development

PrEP4Love was developed by a social marketing committee within the Chicago PrEP Working Group (now IPWG) made up of individuals representing a variety of demographics, perspectives, expertise, and organizational affiliations. Pro bono support was secured through four connected advertising agencies who supported efforts related to creative vision, design, copy, strategy, placement and metric. The team – inclusive of IPWG members and 60 advertising professionals – worked iteratively to develop a campaign prioritizing intimacy and connection. Towards the end of the development process, four focus groups were held with members of target populations. IWPG used input from the focus groups to further refine PrEP4Love and its proposed implementation.

Participants

In order to be enrolled in the RADAR cohort, participants had to meet the following criteria: between 16–29 years of age, assigned male sex at birth, English-speaking, and reported a sexual encounter with a man in the previous year or identified as gay or bisexual. Participants were recruited in three ways: 1) involvement in a cohort of YMSM and/or sexual and gender minority youth (Project Q2,36 Crew 450,37 and a new 2015 cohort) all of which enrolled individuals when they were between 16 and 20 years old; 2) through being a serious partner of an existing RADAR cohort member (i.e., being in a current serious relationship with a RADAR cohort member); or 3) through peer recruitment by an existing RADAR cohort member. Details about the previous cohorts can be found elsewhere;36,37 the new 2015 cohort was recruited using venue-based, peer-referral, and online recruitment methods. All serious partners were eligible for a one-time visit, but were required to meet the above criteria for enrollment in the cohort. Peer recruits needed to meet the same criteria, and needed to be between 16 and 20 years of age. Age was restricted for peer recruits to match the recruitment design of the previous cohorts (i.e., Project Q2 and Crew 450), which at the time of the current study also had older participants (i.e., ages 20–29). The overall RADAR sample needed to represent a full range of ages to achieve the multiple cohort, accelerated longitudinal design.38

Measures

Demographics

At baseline, participants were asked to report their racial identity, and whether they identified as Hispanic or Latino. Following the 2007 United States Department of Education guidelines for combining ethnicity and race data, anyone who identified as Hispanic/Latino regardless of race was classified as Hispanic/Latino.39 All non-Hispanic/Latino individuals who identify as a single race were classified as that race; anyone who identified as two or more races was classified as multiracial. For sample size purposes, Asian, American Indian or Alaska Native, Multi-Racial, and Native Hawaiian or Other Pacific Islander individuals were recoded as “Other.” Other demographic information collected includes age, gender identity, and sexual orientation. The age variable was recoded based on quartiles: 16 to 20, 21 to 22, 23 to 24, and 25 to 31 years.

PrEP Use

Participants were asked if they had ever taken PrEP, whether they had taken PrEP in the last six months, and whether they were currently using PrEP. Follow-up questions varied based on these responses.

PrEP4Love Awareness

Awareness of the PrEP4Love campaign was assessed by asking “Have you seen or heard any advertisement(s) about PrEP (such as the PrEP4Love campaign) in Chicago?” All participants who responded “Yes” were asked “Where did you see or hear the PrEP4Love campaign?

PrEP Attitudes and Perceptions of Usage

Perceived PrEP prevalence was assessed through two questions: “Of all the gay and bisexual men in the United States, how many do you think are on PrEP?” and “Now, thinking about all of your gay and bisexual male friends, how many do you think are on PrEP?” Response options ranged from 1 (Almost None) to 5 (Almost All). Similarly, attitudes about PrEP use were assessed through two questions: “Thinking about all the gay and bisexual men in the United States, how do you think most feel about PrEP?” and “Now, thinking of your gay and bisexual male friends, how do you think most feel about PrEP?” Response options ranged from 1 (Strongly Disapprove) to 5 (Strongly Approve). (Note: participant perceptions of PrEP use among TW or individuals of other genders was not assessed).

PrEP Disclosure

Participants who indicated they had never taken PrEP, but had heard of it were asked the question: “Would you feel comfortable telling anyone that you are taking PrEP if you ever began taking it?” Regardless of PrEP status, all participants were asked “Do you know anyone on PrEP?” Those who responded “Yes” were asked to specify who they knew who was on PrEP.

Provider Conversations and Healthcare

As outness to provider can result in provider-prompted conversations about PrEP,40 all participants were asked “Are you out to your provider as an LGBTQ person?” All participants were also asked “Has a medical provider, such as a doctor or nurse, ever talked to you about PrEP?” All participants who answered “Yes” were asked “Who initiated this conversation about PrEP?” with the options “I did” or “My medical provider did.

Statistical Analysis

All data cleaning and statistical analyses were performed in R Version 3.5.1. Univariate statistics were used to describe participant demographics as well as proportions of individuals who had seen PrEP4Love ads. Regarding PrEP4Love, three domains were of interest: awareness of the campaign, perceptions of PrEP, and interactions with medical providers. First, simple logistic regression was used to determine outcomes of interest. Subsequently, multiple logistic regression models were constructed, controlling for age, race, gender, and sexual orientation. Models relating to PrEP exposure, attitudes, and beahviors also controlled for ever having been on PrEP.

RESULTS

Demographics and Awareness

Similar proportions of the 700-person sample identified as Latinx (31.7%), White (30.3%), and Black (27.0%) (Table 1). Participants were a mean of 22.3 years of age (standard deviation = 2.9; range: 16.4 – 30.7). Gay was the most frequently reported sexual orientation (69.6%), followed by bisexual (17.7%) and queer (7.0%). Participants predominantly identified as cisgender men (91.6%), with a smaller group identifying as transgender women (4.3%) or another gender (4.1%). Nearly one-quarter of participants (24.9%) had ever used PrEP, and approximately one-fifth of participants indicated using PrEP in the prior 6 months (18.9%). Of those, 89 (67.4%) reported current PrEP use.

Table 1.

Demographics and PrEP Characteristics of RADAR Participants (N = 700).

N %

Race/Ethnicity
White 212 30.30
Black or African American 189 27.00
Hispanic/Latinx 222 31.70
Other 77 11.00
Age, years
16 to 20 217 31.00
21 to 22 218 31.10
23 to 24 101 14.40
25 to 31 164 23.40
Sexual Identity
Gay 487 69.60
Bisexual 124 17.70
Queer 49 7.00
Straight/Heterosexual 19 2.70
Unsure/Questioning 8 1.10
Other 13 1.90
Gender Identity
Cisgender Male 641 91.60
Transgender Female 30 4.30
Other 29 4.10
Used PrEP
Ever 174 24.90
Last 6 Months 132 18.90
Currently Using 89 12.71
Heard/seen any ads about PrEP (PrEP4Love) in Chicago 531 75.90
Location:
Internet 307 57.80
At pride events 269 50.70
At local bars/clubs 148 27.80
From friends 186 35.00
From family 27 5.10
From healthcare provider 170 32.00
Chicago Transit Authority (CTA) 136 25.60
Somewhere else 39 7.30

The majority of participants indicated that they had seen a PrEP4Love ad in Chicago (75.9%) (Table 1). Most participants indicated seeing ads on the internet (57.8%). Approximately half reported seeing ads at pride events (50.7%). Fewer participants reported seeing or hearing about ads for PrEP from friends (35.0%), from healthcare providers (32.0%), at local bars or clubs (27.8%), or on Chicago public transportation (CTA; 25.6%). Having ever taken PrEP was associated with seeing PrEP4Love ads (odds ratio [OR] = 2.13; 95% confidence interval [CI]: 1.34, 3.36); subsequent analyses relating to seeing ads controlled for having ever been on PrEP.

PrEP4Love Impact on Health Beliefs and Behaviors

After controlling for ever having been on PrEP, individuals who had seen ads were significantly more likely to be out to their medical provider (OR = 1.67; 95% CI: 1.00, 2.82) and to have had a conversation about PrEP with a medical provider (OR = 2.52; 95% CI: 1.69, 3.75) than those who had not seen ads (Table 2). Of these individuals, those who had seen PrEP4Love ads were significantly more likely to have initiated the conversation (OR = 2.07; 95% CI: 1.12, 3.82). Further, individuals who had seen ads were also more likely to have taken PrEP in the past 6 months (OR = 1.99; 95% CI: 1.20, 3.30; ever PrEP users, but not in last 6 months, were excluded [n = 41]). Of those who had never taken PrEP, individuals who had seen ads were more likely to indicate that they would feel comfortable disclosing PrEP use if they ever began taking it (OR = 1.89; 95% CI: 1.08, 3.28). After controlling for age, race/ethnicity, sexual identity, and gender identity, adjusted ORs (AORs) for the above associations only differed slightly from unadjusted ORs, with no changes in significance.

Table 2.

PrEP Attitudes and Uptake Behaviors Associated with Seeing PrEP4Love Ads

Seen Ad for PrEP4Love (N = 700)
N (%) OR 95% CI AOR 95% CI

Among GBM in the US, how many do you think are on PrEP?
1 - Almost None 30 (4.3) 1.00 (−) 1.00 (−)
2 242 (34.6) 1.36 (0.61, 3.06) 1.44 (0.62, 3.33)
3 337 (48.1) 1.91 (0.85, 4.26) 1.84 (0.80, 4.21)
4 64 (9.1) 1.79 (0.68, 4.68) 1.56 (0.58, 4.23)
5 - Almost All 27 (3.9) 0.85 (0.29, 2.53) 0.66 (0.21, 2.05)
Among all of your GBM friends, how many do you think are on PrEP?
1 - Almost None 281 (40.1) 1.00 (−) 1.00 (−)
2 166 (23.7) 3.54 (2.18, 5.97) 3.54 (2.15, 6.01)
3 156 (22.3) 2.30 (1.46, 3.69) 2.20 (1.37, 3.59)
4 63 (9.0) 3.92 (1.89, 9.19) 4.96 (1.93, 9.63)
5 - Almost All 34 (4.9) 3.31 (1.35, 9.95) 3.40 (1.34, 10.52)
Among GBM in the US, how do you think most feel about PrEP?
1 - Strongly Disapprove 9 (1.3) 1.00 (−) 1.00 (−)
2 31 (4.4) 2.63 (0.58, 12.76) 3.57 (0.71, 20.02)
3 249 (35.6) 3.26 (0.84, 13.51) 4.49 (1.03, 21.86)
4 223 (31.9) 4.33 (1.11, 18.05) 6.32 (1.44, 31.11)
5 - Strongly Approve 188 (26.9) 5.46 (1.38, 23.08) 7.41 (1.67, 36.68)
Among all of your GBM friends, how do you think most feel about PrEP?
1 - Strongly Disapprove 15 (2.1) 1.00 (−) 1.00 (−)
2 41 (5.9) 4.25 (1.16, 16.19) 4.15 (1.10, 16.27)
3 200 (28.6) 2.31 (0.78, 6.73) 2.35 (0.77, 7.10)
4 174 (24.9) 2.59 (0.86, 7.61) 2.82 (0.90, 8.64)
5 - Strongly Approve 270 (38.6) 3.34 (1.13, 9.71) 3.52 (1.15, 10.58)
Are you out to your provider as an LGBTQ person? (N = 378)
No 108 (28.6) 1.00 (−) 1.00 (−)
Has a medical provider, like a doctor or nurse, ever talked to you about PrEP?
No 332 (47.4) 1.00 (−) 1.00 (−)
Yes 368 (52.6) 2.77 (1.93, 4.00) 2.76 (1.91, 4.01)
Who initiated this conversation about PrEP? (N = 368)
My Provider Did 170 (46.2) 1.00 (−) 1.00 (−)
I Did 198 (53.8) 2.07 (1.15, 3.85) 2.24 (1.23, 4.25)
Have you taken PrEP in the past 6 months?
No 567 (81.0) 1.00 (−) 1.00 (−)
Yes 133 (19.0) 1.87 (1.15, 3.16) 1.86 (1.13, 3.18)
If you began taking PrEP would you feel comfortable telling someone? (N = 566)
No 64 (11.3) 1.00 (−) 1.00 (−)
Yes 502 (88.7) 1.98 (1.14, 3.38) 2.02 (1.14, 3.52)
Do you know anyone on PrEP?
No 259 (37.0) 1.00 (−) 1.00 (−)
Yes 441 (63.0) 2.87 (2.02, 4.11) 3.02 (2.07, 4.44)

Individuals who had seen PrEP4Love ads more commonly believed that GBM in their social circles and in general approved of and were taking PrEP. People who had seen ads were significantly more likely to perceive their GBM friends as strongly approving of PrEP, as compared to strongly disapproving, than those who had not seen ads (AOR = 3.85; 95% CI: 1.28, 11.6). Similarly, they were also more likely to believe that all GBM in the country strongly approved of PrEP, as compared to strongly disapproving, than those who had not seen ads (AOR = 8.02; 95% CI: 1.78, 36.1). Finally, people who had seen ads were more likely to perceive that almost all of their GBM friends were on PrEP, as compared to perceiving that none of their friends were on PrEP, than those who had not seen ads (AOR = 3.59; 95% CI: 1.18, 10.9). People who reported seeing ads for PrEP were more likely to know someone on PrEP (AOR = 2.85, 95% CI: 1.95, 4.17). All analyses controlled for having ever taken PrEP.

DISCUSSION

PrEP4Love’s mission is to increase awareness and uptake of PrEP and to break uptake-inhibiting stigmas related to PrEP. Although our data prohibits causal inference, there is evidence to suggest that PrEP4Love may have been successful. Individuals who had seen ads were more likely to be on PrEP and more likely to believe that people perceived PrEP to be widely used by GBM. Accordingly, participants who reported not seeing ads were significantly more likely to believe that almost no GBM in the US were on PrEP. Conversely, individuals who had seen ads tended to believe that GBM in general had a more positive view of PrEP than those who had not. This may indicate that individuals viewing PrEP4Love messaging perceive less stigma associated with PrEP use within the GBM community, which increases the likelihood of future PrEP usage.

We also found that participants who had seen PrEP4Love ads were more likely to know someone on PrEP. This could be potentially interpreted as evidence that seeing PrEP advertisements leads individuals to seek out more information about PrEP from social connections. However, caution should be exercised as it is entirely possible that perceptual bias plays a role in these results, especially considering the positive association between having ever used PrEP and seeing PrEP4Love ads. Subsequent analyses controlled for having ever been on PrEP, improving the rigor of the associations, but other factors could also potentially drive perceptual bias. Individuals who know someone on PrEP may be more familiar with the medication, and therefore more likely to notice PrEP ads. Similarly, those who hold prior beliefs that many GBM are on PrEP, or perceive PrEP positively, may be more likely to notice ads. Given that paid PrEP4Love campaign advertising on transit had concluded several months in advance of our assessment, it is possible that PrEP4Love exposure may have led to increased PrEP information seeking. To alleviate the temporal uncertainty of these analyses, rigorous longitudinal evaluation of PrEP promotional campaigns is needed.

Individuals who had seen PrEP4Love materials were more likely to indicate comfort with disclosing PrEP status if they ever began using it. This has important implications for uptake, as PrEP stigma is a significant known barrier.41,42 Prior analyses within the RADAR cohort have identified the importance of PrEP disclosure to social support, which can be key to effective PrEP adherence.40 Furthermore, findings demonstrate that seeing ads is associated with key steps towards PrEP uptake. Individuals who had seen ads were more likely to be out to their providers, to have had a conversation about PrEP with their provider, and to have initiated aforementioned conversation. This suggests that PrEP publicity campaigns could play a role in facilitating service connectivity and patient-provider interactions that lead to PrEP prescription. Again, however, the non-longitudinal nature of the data available prohibits causal inferences, although the time between conclusion of paid out-of-home advertising and this assessment (transit ads ended more than 6 months before the survey, which asked about PrEP use in the prior 6 months) lends some credence to the interpretation that PrEP4Love helped to facilitate service connectivity. There is additional evidence in favor of a temporal relationship, as participants in our study who had seen ads for PrEP were more likely to have taken PrEP in the last six months. These encouraging findings emphasize the need for longitudinal research in future PrEP messaging implementation resaerch.

We also observed that Black and Latinx individuals were more likely than White participants to learn about campaign materials from their friends. Understanding the influence of social networks and how information is diffused into specific communities may be especially salient in developing methods to target populations with the lowest PrEP uptake and adherence.4346 For example, the network-based Popular Opinion Leader (POL) intervention has shown potential in improving numerous health outcomes, including increasing HIV preventive knowledge and behaviors, and reducing HIV stigma, among others,4749 and may be an effective means to support PrEP uptake in underserved populations.50 Results from similar future analyses of campaign implementation could help to better specify existing effective interventions based on a detailed understanding of demographic-specific social contexts.

Findings related to gender identity added additional nuance. TWwere more likely than cisgender men to receive information about the PrEP4Love campaign from healthcare providers. There are several possible explanations for the result. First, TW are at elevated average risk for contracting HIV, which could potentially lead to more conversations related to PrEP when clinicians are aware of both this disparity and their patient’s gender identity. Second, TW often have multiple healthcare providers,51 which could increase the likelihood that at least one provider might initiate a conversation about PrEP. Relatedly, TW – particularly TW seeking gender-affirming medical care – may be more likely to be “out” to their care providers (depending on the health services sought) which, as we observed, increases the likelihood of physicians initiating a conversation about PrEP. Regardless of precise cause, this finding points to the importance of the care provider in PrEP uptake among TW specifically, and future PrEP campaigns may benefit from targeting messaging towards healthcare providers as well. Moreover, future research should consider potentially unique experiences of PrEP, PrEP providers, and PrEP advertising at the various intersections of racial, ethnic, gender, and sexual identities; qualitative inquiry may prove useful in disentangling these complex associations.

Limitations

The primary limitation is that data were cross-sectional. Therefore, we cannot specify directionality in associations between PrEP4Love exposure and outcomes. However, this limitation is not sufficient to eliminate PrEP4Love advertising as a potential causal factor in PrEP awareness and uptake. Future studies should longitudinally assess the impact of PrEP campaigns in order to eliminate this uncertainty. Crucially, if future research reveals that perceptual bias is driving these associations, rather than messaging impact, PrEP messaging campaigns should take this information into account when planning how best to reach their target populations. Further, because there was no picture identification of the PrEP4Love campaign for participants, it is possible that other PrEP campaigns were captured in our outcomes. Future studies could consider including visual prompts to ensure recall specificity. Moreover, while our sample of MSM and TW was large and diverse, it was entirely Chicago-based, which prevents generalization to TW and MSM at large. Our sample also had few transgender participants, and questions on PrEP attitudes and perceptions were geared exclusively towards GBM. Studies which include TW alongside MSM must be intentional in their development to ensure appropriate sample size and question design for analyses with transgender participants.

Conclusions

This study presents promising results surrounding the potential impact of targeted messaging and prevention advocacy campaigns on PrEP attitudes, perceptions and behaviors. Campaigns such as PrEP4Love could play an important role in HIV prevention, targeting barriers to care that health service provision interventions may have difficulty alleviating such as stigma and negative attitudes. This study’s specific strengths and limitations also serve to identify critical considerations for evaluation of messaging interventions. Continued implementation research in messaging and prevention advocacy is integral to establishing evidence-based approaches for this promising form of intervention.

Acknowledgments

Sources of Support: Third Coast Center for AIDS Research: P30 AI117943, D’Aquila (PI).

National Institute on Drug Abuse: U01 DA036939, Mustanski (PI).

REFERENCES

  • 1.Centers for Disease Control and Prevention. Estimated HIV incidence and prevalence in the United States, 2010–2015. HIV Surveillance Supplemental Report. 2018;23(1). [Google Scholar]
  • 2.Centers for Disease Control and Prevention. Diagnoses of HIV Infection in the United States and Dependent Areas, 2017. Vol 29 Atlanta, GA: Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention (CDC), U.S. Department of Health and Human Services; 2018. [Google Scholar]
  • 3.Centers for Disease Control and Prevention. Diagnoses of HIV Infection in the United States and Dependent Areas, 2016. In: Services DoHaH, ed. Vol 28 Atlanta, Georgia: Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention (CDC), U.S. Department of Health and Human Services; 2017. [Google Scholar]
  • 4.Centers for Disease Control and Prevention. HIV Among African Americans. CDC Fact Sheet. 2015:1–2. [Google Scholar]
  • 5.Centers for Disease Control and Prevention. HIV Among African American Gay and Bisexual Men. https://www.cdc.gov/hiv/group/msm/bmsm.html. Published 2018. Accessed 02/15/2018.
  • 6.Centers for Disease Control and Prevention. HIV Among Latinos. Atlanta, Georgia: Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention (CDC), U.S. Department of Health and Human Services; 2017. [Google Scholar]
  • 7.Centers for Disease Control and Prevention. CDC Fact Sheet: HIV Among Youth. In: Prevention CfDCa, ed 2017. [Google Scholar]
  • 8.Centers for Disease Control and Prevention. HIV and Transgender People. CDC Fact Sheet. 2018. [Google Scholar]
  • 9.Buchbinder SP, Glidden DV, Liu AY, et al. HIV pre-exposure prophylaxis in men who have sex with men and transgender women: a secondary analysis of a phase 3 randomised controlled efficacy trial. The Lancet Infectious Diseases. 2014;14(6):468–475. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Deutsch MB, Glidden DV, Sevelius J, et al. HIV pre-exposure prophylaxis in transgender women: a subgroup analysis of the iPrEx trial. Lancet HIV. 2015;2(12):E512–E519. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Grant RM, Lama JR, Anderson PL, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. New England Journal of Medicine. 2010;363(27):2587–2599. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Eaton LA, Matthews DD, Driffin DD, et al. A Multi-US City Assessment of Awareness and Uptake of Pre-exposure Prophylaxis (PrEP) for HIV Prevention Among Black Men and Transgender Women Who Have Sex with Men. Prevention Science. 2017;18(5):505–516. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Getting to Zero Exploratory Workgroup. Getting To Zero: A Framework to Eliminate HIV in Illinois. 2017. [Google Scholar]
  • 14.Strauss BB, Greene GJ, Phillips G 2nd, et al. Exploring Patterns of Awareness and Use of HIV Pre-Exposure Prophylaxis Among Young Men Who Have Sex with Men. AIDS and Behavior. 2017;21(5):1288–1298. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Smith DK, Van Handel M, Wolitski RJ, et al. Vital Signs: Estimated Percentages and Numbers of Adults with Indications for Preexposure Prophylaxis to Prevent HIV Acquisition--United States, 2015. MMWR Morbidity and Mortality Weekly Report. 2015;64(46):1291–1295. [DOI] [PubMed] [Google Scholar]
  • 16.Hoots BE, Finlayson T, Nerlander L, Paz-Bailey G, National HIV Behavioral Surveillance Study Group. Willingness to Take, Use of, and Indications for Pre-exposure Prophylaxis Among Men Who Have Sex With Men-20 US Cities, 2014. Clinical Infectious Diseases. 2016;63(5):672–677. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Eaton LA, Driffin DD, Bauermeister J, Smith H, Conway-Washington C. Minimal Awareness and Stalled Uptake of Pre-Exposure Prophylaxis (PrEP) Among at Risk, HIV-Negative, Black Men Who Have Sex with Men. AIDS Patient Care STDS. 2015;29(8):423–429. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Centers for Disease Control and Prevention. CDC Fact Sheet: HIV among Gay and Bisexual Men. 2015.
  • 19.Khanna AS, Michaels S, Skaathun B, et al. Preexposure Prophylaxis Awareness and Use in a Population-Based Sample of Young Black Men Who Have Sex With Men. JAMA Internal Medicine. 2016;176(1):136–138. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Perez-Figueroa RE, Kapadia F, Barton SC, Eddy JA, Halkitis PN. Acceptability of PrEP Uptake Among Racially/Ethnically Diverse Young Men Who Have Sex With Men: The P18 Study. AIDS Education Prevention. 2015;27(2):112–125. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Lelutiu-Weinberger C, Golub SA. Enhancing PrEP Access for Black and Latino Men Who Have Sex With Men. Journal of Acquired Immune Deficiency Syndrome. 2016;73(5):547–555. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Bourne A, Cassolato M, Thuan Wei CK, et al. Willingness to use pre-exposure prophylaxis (PrEP) for HIV prevention among men who have sex with men (MSM) in Malaysia: findings from a qualitative study. Journal of the International AIDS Society. 2017;20(1):21899. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Eaton LA, Kalichman SC, Price D, Finneran S, Allen A, Maksut J. Stigma and Conspiracy Beliefs Related to Pre-exposure Prophylaxis (PrEP) and Interest in Using PrEP Among Black and White Men and Transgender Women Who Have Sex with Men. AIDS and Behavior. 2017;21(5):1236–1246. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Cahill S, Taylor SW, Elsesser SA, Mena L, Hickson D, Mayer KH. Stigma, medical mistrust, and perceived racism may affect PrEP awareness and uptake in black compared to white gay and bisexual men in Jackson, Mississippi and Boston, Massachusetts. AIDS Care 2017;29(11):1351–1358. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Sevelius JM, Keatley J, Calma N, Arnold E. “I am not a man’: Trans-specific barriers and facilitators to PrEP acceptability among transgender women. Global Public Health. 2016;11(7–8):1060–1075. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Platt T, Platt J, Thiel DB, Kardia SL. Facebook Advertising Across an Engagement Spectrum: A Case Example for Public Health Communication. JMIR Public Health Surveillance. 2016;2(1):e27. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Duke JC, Farrelly MC, Alexander TN, et al. Effect of a National Tobacco Public Education Campaign on Youth’s Risk Perceptions and Beliefs About Smoking. American Journal of Health Promotion. 2018;32(5):1248–1256. [DOI] [PubMed] [Google Scholar]
  • 28.Siegel M. Mass media antismoking campaigns: a powerful tool for health promotion. Annual Internal Medicine. 1998;129(2):128–132. [DOI] [PubMed] [Google Scholar]
  • 29.Freeman B, Potente S, Rock V, McIver J. Social media campaigns that make a difference: what can public health learn from the corporate sector and other social change marketers? Public Health Research and Practice. 2015;25(2). [DOI] [PubMed] [Google Scholar]
  • 30.Jones J, Salazar LF. A Review of HIV Prevention Studies that Use Social Networking Sites: Implications for Recruitment, Health Promotion Campaigns, and Efficacy Trials. AIDS and Behavior. 2016;20(11):2772–2781. [DOI] [PubMed] [Google Scholar]
  • 31.Mustanski B, Ryan DT, Hayford C, Phillips G 2nd, Newcomb ME, Smith JD. Geographic and Individual Associations with PrEP Stigma: Results from the RADAR Cohort of Diverse Young Men Who have Sex with Men and Transgender Women. AIDS and Behavior. 2018;22(9):3044–3056. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Almasi EA, Stafford RS, Kravitz RL, Mansfield PR. What are the public health effects of direct-to-consumer drug advertising? PLOS Medicine. 2006;3(3):284–288. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Sivanathan N, Kakkar H. The unintended consequences of argument dilution in direct-to-consumer drug advertisements. Nature Human Behaviour. 2017;1(11):797–802. [DOI] [PubMed] [Google Scholar]
  • 34.Schnipper LE, Abel GA. Direct-to-Consumer Drug Advertising in Oncology Is Not Beneficial to Patients or Public Health. Jama Oncol. 2016;2(11):1397–1398. [DOI] [PubMed] [Google Scholar]
  • 35.Green CE, Mojtabai R, Cullen BA, Spivak A, Mitchell M, Spivak S. Exposure to Direct-to-Consumer Pharmaceutical Advertising and Medication Nonadherence Among Patients With Serious Mental Illness. Psychiatric Services. 2017;68(12):1299–1302. [DOI] [PubMed] [Google Scholar]
  • 36.Mustanski B, Garofalo R, Emerson EM. Mental health disorders, psychological distress, and suicidality in a diverse sample of lesbian, gay, bisexual, and transgender youths. American Journal of Public Health. 2010;100(12):2426–2432. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Mustanski B, Johnson AK, Garofalo R, Ryan D, Birkett M. Perceived Likelihood of Using HIV Pre-exposure Prophylaxis Medications Among Young Men Who Have Sex With Men. AIDS and Behavior. 2013;17(6):2173–2179. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Miyazaki Y, Raudenbush SW. Tests for linkage of multiple cohorts in an accelerated longitudinal design. Psychological Methods. 2000;5(1):44–63. [DOI] [PubMed] [Google Scholar]
  • 39.U.S. Department of Education. Final Guidance on Maintaining, Collecting, and Reporting Racial and Ethnic Data to the U.S. Department of Education In: Education USDo, ed. Vol 72 FR 59266. Federal Register: U.S. Department of Education; 2007. [Google Scholar]
  • 40.Phillips G, Raman A, Felt D, Han Y, Mustanski B. Factors Associated with PrEP Support and Disclosure Among YMSM and Transgender Individuals Assigned Male at Birth in Chicago. AIDS and Behavior. 2019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Arnold T, Brinkley-Rubinstein L, Chan PA, et al. Social, structural, behavioral and clinical factors influencing retention in Pre-Exposure Prophylaxis (PrEP) care in Mississippi. PLOS One. 2017;12(2):e0172354. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Franks J, Hirsch-Moverman Y, Loquere AS Jr., et al. Sex, PrEP, and Stigma: Experiences with HIV Pre-exposure Prophylaxis Among New York City MSM Participating in the HPTN 067/ADAPT Study. AIDS and Behavior. 2017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Phillips G 2nd, Neray B, Birkett M, Felt D, Janulis P, Mustanski B. Role of Social and Sexual Network Factors in PrEP Utilization Among YMSM and Transgender Women in Chicago. Prevention Science. 2019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Duncan DT, Hickson DA, Goedel WC, et al. The Social Context of HIV Prevention and Care among Black Men Who Have Sex with Men in Three U.S. Cities: The Neighborhoods and Networks (N2) Cohort Study. International Jounral of Environmental and Public Health. 2019;16(11):1922. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Khanna AS, Schumm P, Schneider JA. Facebook network structure and awareness of preexposure prophylaxis among young men who have sex with men. Annals of Epidemiology. 2017;27(3):176–180. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Schneider JA, Walsh T, Cornwell B, Ostrow D, Michaels S, Laumann EO. HIV health center affiliation networks of black men who have sex with men: disentangling fragmented patterns of HIV prevention service utilization. Sexually Transmitted Diseases. 2012;39(8):598–604. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Kelly JA, St Lawrence JS, Diaz YE, et al. HIV risk behavior reduction following intervention with key opinion leaders of population: an experimental analysis. American Journal of Public Health. 1991;81(2):168–171. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Theall KP, Fleckman J, Jacobs M. Impact of a community popular opinion leader intervention among African American adults in a southeastern United States community. AIDS Education and Prevention. 2015;27(3):275–287. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Li L, Guan J, Liang L-J, Lin C, Wu Z. Popular Opinion Leader intervention for HIV stigma reduction in health care settings. AIDS Education and Prevention. 2013;25(4):327–335. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Young LE, Schumm P, Alon L, et al. PrEP Chicago: A randomized controlled peer change agent intervention to promote the adoption of pre-exposure prophylaxis for HIV prevention among young Black men who have sex with men. Clinical Trials. 2018;15(1):44–52. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Birkett M, Neray B, Janulis P, Phillips G, 2nd, Mustanski B. Intersectional Identities and HIV: Race and Ethnicity Drive Patterns of Sexual Mixing. AIDS and Behavior. 2019;23(6):1452–1459. [DOI] [PMC free article] [PubMed] [Google Scholar]

RESOURCES